Jane Street Group, LLC Timber Pharmaceuticals, Inc. Transaction History

Jane Street Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 17, 2022	SELL	$0.28 - $0.41 $15,121 - $22,142	-54,006 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$0.38 - $0.89 $20,522 - $48,065	54,006 New	54,006 $21,000
Q2 2021 Aug 16, 2021	SELL	$1.06 - $2.25 $47,989 - $101,864	-45,273 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$0.81 - $3.55 $36,671 - $160,719	45,273 New	45,273 $92,000

Ticker TMBR
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,524,992
Description
Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company's lead product candidates include TMB-001, a patented topical formulation of isotretinoin that has completed Phase 2b clinical trial for the treatment of moderate to ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.